Glass House BrandsGLASF -2.28%44 Market Cap is $1,057.9 Mil as of Jun. 26, 2026. GuruFocus rates GLASF with a GF Score™ of 44/100 and a GF Value™ of $6.15 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,023 Drug Manufacturers companies, Glass House Brands ranks better than 76.93% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Glass House Brands's share price for the quarter that ended in Mar. 2026 was $8.16. Glass House Brands's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 84.7 Mil. Therefore, Glass House Brands's market cap for the quarter that ended in Mar. 2026 was $690.9 Mil.
Glass House Brands's quarterly market cap
increased
from Sep. 2025 ($599.9 Mil) to Dec. 2025 ($723.3 Mil) but then
declined
from Dec. 2025 ($723.3 Mil) to Mar. 2026 ($690.9 Mil).
Glass House Brands's annual market cap
increased
from Dec. 2023 ($335.6 Mil) to Dec. 2024 ($446.1 Mil) and
increased
from Dec. 2024 ($446.1 Mil) to Dec. 2025 ($723.3 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Glass House Brands's Enterprise Value for Today is $1,222.9 Mil.
Glass House Brands (OTCPK:GLASF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Glass House Brands Market Cap Related Terms
Glass House Brands Market Cap Historical Data
* Premium members only.
The historical data trend for Glass House Brands's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Glass House Brands's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glass House Brands Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Glass House Brands's Market Cap distribution charts can be found below:
* The bar in red indicates where Glass House Brands's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Glass House Brands's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glass House Brands (GLASF) has a Market Cap of $1,057.9 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Glass House Brands and its competitors. According to the industry distribution chart, Glass House Brands ranks #236 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 23.1%.
Is Glass House Brands' Market Cap too high?
Glass House Brands' current Market Cap is $1,057.9 Mil. The Drug Manufacturers industry median Market Cap is 205.37. Glass House Brands' value of $1,057.9 Mil is 415.1% above this industry median. Based on the distribution chart, Glass House Brands ranks #236 out of 1023 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Glass House Brands has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Glass House Brands' Market Cap compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Glass House Brands ranks #236 out of 1023 companies for Market Cap. This places Glass House Brands in the top 23% of its industry — outperforming the majority of peers. The industry median Market Cap is 205.37. Glass House Brands' value of $1,057.9 Mil is 415.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 205.37, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Glass House Brands's current Market Cap of $1,057.9 Mil is 415.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Glass House Brands and its competitors. For the Drug Manufacturers industry, the median Market Cap is 205.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glass House Brands's current Market Cap is $1,057.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glass House Brands stock overvalued right now?
Based on GuruFocus' analysis, Glass House Brands (GLASF) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.15, compared to a current price of $12.45 — trading 102.4% above its estimated fair value. The current Market Cap is $1,057.9 Mil and 415.1% above the Drug Manufacturers industry median of 205.37. Glass House Brands' overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Glass House Brands (GLASF), the current Market Cap is $1,057.9 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Glass House Brands (GLASF) Overvalued in 2026?
Based on GuruFocus' analysis, Glass House Brands stock appears to be overvalued.
The current stock price of $12.45 is trading 102.4% above its estimated GF Value™ of $6.15.
GuruFocus considers Glass House Brands to be Significantly Overvalued.
Key valuation signals for GLASF:
Market Cap: $1,057.9 Mil
GF Value™: $6.15 vs. price of $12.45 (102.4% above fair value)
Industry Position: 415.1% above the Drug Manufacturers median (#236 of 1023)
No single metric tells the full story. See the GLASF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.
44GF Score
Get the complete analysis for GLASF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLASF has been successfully added to your 
